Psychiatric complications of 'Ecstasy' use
Hugh Series, Sietske Boeles, Eluned Dorkins, Robert Peveler
Journal of Psychopharmacology 1994 DOI: 10.1177/026988119400800110 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 2 |
| Population | Two individuals who had ingested 'Ecstasy' (MDMA) |
| Interventions | 'Ecstasy' (3 4-methylenedioxymethamphetamine) |
| Duration | At least one month in one case; more than 8 weeks in the other |
| Topics | MDMA |
| Citations | 44 |
| Key findings | Two case reports describe significant psychiatric disorders after 'Ecstasy' (MDMA) use: one patient developed a brief paranoid psychosis that recurred and persisted for at least a month after a second dose, and another experienced anxiety and depression lasting more than eight weeks. |
Abstract
Two case reports are presented of significant psychiatric disorders associated with ingestion of 'Ecstasy' (3,4-methylenedioxymethamphetamine), a recreational drug whose use appears to be increasing. In one case, the patient developed a brief paranoid psychosis which recurred and persisted for at least a month after he took a second dose of the drug. In the other, the patient experienced persistent symptoms of anxiety and depression for > 8 weeks after taking the drug.